Clindamycin Hydrochloride
Product Images NDC 10544-154

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 10544-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mg 30ct (Label Clindamycin HCl Caps 300mg Bpi(10544 154 30) Watson(0591 3120 01) Rev1)

300mg 30ct (Label Clindamycin HCl Caps 300mg Bpi(10544 154 30) Watson(0591 3120 01) Rev1)
Clindamycin Hydrochloride Capsules, USP 300mg 30 Capsules are a prescription medication distributed by Watson Pharma, Inc. The medicine is packaged in opaque, light-resistant containers and should be stored at a controlled room temperature between 68°F-77°F. Each capsule contains 300mg of Clindamycin Hydrochloride and is labeled with a lot number and expiration date. It is important to keep out of the reach of children. This medication is used to treat bacterial infections. No additional information could be gathered due to poor quality.*
FDA Label Image

Structure (Clindamycin HCl Capsule 1)

FDA Label Image

Table 1 (Clindamycin HCl Capsule 2)

Table 1 (Clindamycin HCl Capsule 2)
This is a table that provides the susceptibility interpretive criteria for Clindamycin. It includes the minimal inhibitory concentrations and disk diffusion values for different pathogens such as Staphylococcus spp., Streptococcus spp., and Anaerobic Bacteria. "N/A" is also listed as not applicable.*
FDA Label Image

Table 2 (Clindamycin HCl Capsule 3)

Table 2 (Clindamycin HCl Capsule 3)
This is a table containing acceptable quality control ranges for Clindamycin used in validating susceptibility test results for aerobic pathogens and anaerobes. The table includes Qc strain, minimum inhibitory concentration range in meg/m, and disk diffusion range in mm. The acceptable ranges for Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, Streptococcus pneumoniae ATCC 49619, Bacteraides fragilis ATCC 25285, Bacteroides thetaiotaomicron ATCC 29741, and Eubacterium lentum ATCC 43055 are given. NA means not applicable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.